Unknown

Dataset Information

0

Donation of mitochondria by iPSC-derived mesenchymal stem cells protects retinal ganglion cells against mitochondrial complex I defect-induced degeneration.


ABSTRACT: Rationale: Retinal ganglion cell (RGC) degeneration is extremely hard to repair or regenerate and is often coupled with mitochondrial dysfunction. Mesenchymal stem cells (MSCs)-based treatment has been demonstrated beneficial for RGC against degeneration. However, underlying mechanisms of MSC-provided RGC protection are largely unknown other than neuroprotective paracrine actions. In this study, we sought to investigate whether mitochondrial donation from induced pluripotent stem cell-derived MSC (iPSC-MSCs) could preserve RGC survival and restore retinal function. Methods: iPSC-MSCs were injected into the vitreous cavity of one eye in NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) knockout (KO) and wild type mice. Phosphate buffer saline (PBS) or rotenone treated iPSC-MSCs were injected as control groups. Retinal function was detected by flash electroretinogram (ERG). Whole-mount immunofluorescence (IF), morphometric analysis, confocal microscopy imaging, polymerase chain reaction (PCR) of the retinas were conducted to investigate mitochondrial transfer from human iPSC-MSCs to mouse retina. Quantitative mouse cytokine arrays were carried out to measure retinal inflammatory response under difference treatments. Results: RGC survival in the iPSC-MSC injected retina of Ndufs4 KO mice was significantly increased with improved retinal function. GFP labelled human mitochondria from iPSC-MSC were detected in the RGCs in the retina of Ndufs4 KO mice starting from 96 hours post injection. PCR result showed only human mitochondrial DNA without human nuclear DNA could be detected in the mouse retinas after iPSC-MSC treatment in Ndufs4 KO mice eye. Quantitative cytokine array analysis showed pro-inflammatory cytokines was also downregulated by this iPSC-MSC treatment. Conclusion: Intravitreal transplanted iPSC-MSCs can effectively donate functional mitochondria to RGCs and protect against mitochondrial damage-induced RGC loss.

SUBMITTER: Jiang D 

PROVIDER: S-EPMC6531297 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Donation of mitochondria by iPSC-derived mesenchymal stem cells protects retinal ganglion cells against mitochondrial complex I defect-induced degeneration.

Jiang Dan D   Xiong Guoyin G   Feng Hong H   Zhang Zhao Z   Chen Peikai P   Yan Bin B   Chen Ling L   Gandhervin Kesavamoorthy K   Ma Chuiyan C   Li Cheng C   Han Shuo S   Zhang Yuelin Y   Liao Can C   Lee Tin-Lap TL   Tse Hung-Fat HF   Fu Qing-Ling QL   Chiu Kin K   Lian Qizhou Q  

Theranostics 20190413 8


<b>Rationale</b>: Retinal ganglion cell (RGC) degeneration is extremely hard to repair or regenerate and is often coupled with mitochondrial dysfunction. Mesenchymal stem cells (MSCs)-based treatment has been demonstrated beneficial for RGC against degeneration. However, underlying mechanisms of MSC-provided RGC protection are largely unknown other than neuroprotective paracrine actions. In this study, we sought to investigate whether mitochondrial donation from induced pluripotent stem cell-der  ...[more]

Similar Datasets

| S-EPMC8058353 | biostudies-literature
| S-EPMC7253479 | biostudies-literature
| S-EPMC7652757 | biostudies-literature
| S-EPMC7005343 | biostudies-literature
| S-EPMC10093228 | biostudies-literature
| S-EPMC3646795 | biostudies-literature
| S-EPMC9558835 | biostudies-literature
| S-EPMC7058433 | biostudies-literature
| S-EPMC6996954 | biostudies-literature